| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 146,854,000 | 26.51% | ||
| 2 | ABIOMED INC | 2,150,000 | 141,319,000 | 25.51% | ||
| 3 | CORIUM INTERNATIONAL INC | 9,353,304 | 128,047,000 | 23.11% | ||
| 4 | ENTELLUS MEDICAL INC | 3,813,197 | 98,647,000 | 17.80% | ||
| 5 | ENDOLOGIX INC | 1,257,468 | 24,875,000 | 4.49% | ||
| 6 | ACURA PHARMACEUTICALS INC | 9,871,985 | 9,684,000 | 1.75% | ||
| 7 | MEDICINOVA INC COM NEW | 1,170,370 | 4,623,000 | 0.83% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001458, filed 2015.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
